Received Mar 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 9PG49 | — |
a patient got an expired dose of Engerix-B on March 7th 2025; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 13-year-old male patient who received HBV (Engerix B) (batch number 9PG49, expiry date 28-DEC-2024) for prophylaxis. Previously administered products included Hepatitis B vaccines (Patient got prior Hepatitis B vaccines 1 st dose on February 8th 2012) and Hepatitis B vaccines (Patient got prior Hepatitis B vaccines 2nd on 30-APR-2012). On 07-MAR-2025, the patient received Engerix B. On 07-MAR-2025, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: a patient got an expired dose of Engerix-B on March 7th 2025). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 07-MAR-2025 Certified Medical Assistant explained that a patient got an expired dose of Engerix-B on March 7th 2025, which led to Expired vaccine used. The dose was expired on December 28th, 2024. Patient got 2 prior Hepatitis B vaccines on February 8th, 2012, and April 30th, 2012. Lot number and expiration date for the prior 2 doses were unknown by the caller, and brand name was not mentioned. The reporter consented to follow up.